Ardent Health (NYSE: ARDT) has recently appointed Robert A. Demichiei, a seasoned leader with over 30 years of experience in financial strategy and healthcare operations, to its board of directors. Mr. Demichiei has a notable background, having served as the executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020.
With the addition of Mr. Demichiei to the board, Ardent Health aims to benefit from his extensive experience in driving financial growth and leading strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements at UPMC.
Mr. Demichiei's impressive track record also includes executive roles with the General Electric Company and PricewaterhouseCoopers. He currently serves on the boards of several organizations, including Waystar Holding Corp. (NASDAQ: WAY), Ampco-Pittsburgh Corporation (NYSE: AP), and Auto Club Enterprises/AAA. Additionally, he is a strategic advisor to Health Catalyst (NASDAQ: HCAT) and Omega Healthcare Management Services.
In his new role at Ardent Health, Mr. Demichiei will serve on the board's audit & compliance committee and the nominating & corporate governance committee. His governance experience with publicly traded companies is expected to bring valuable insight and perspective to the board.
Ardent Health, a leading provider of healthcare in growing mid-sized urban communities across the U.S., operates through a system of 30 acute care hospitals and 280 sites of care with over 1,800 affiliated providers across six states. The company is known for its focus on people and investments in innovative services and technologies, with a passionate commitment to making healthcare better and easier to access. As a result of these announcements, the company's shares have moved -3.8% on the market, and are now trading at a price of $12.31. For more information, read the company's full 8-K submission here.
